Contact this trialFirst, we need to learn more about you.
Anti-metabolites
Artesunate for Pulmonary Arterial Hypertension
Recruiting1 awardPhase 1
Stanford, California
This trial is a 20-week study that is testing the safety and tolerance of a medication called artesunate in patients with pulmonary arterial hypertension.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service